Shares of Johnson & Johnson and Goldman Sachs Group Inc. were the biggest drags on the Dow Jones Industrial Average even as both companies reported...
Shares of Johnson & Johnson JNJ and Goldman Sachs Group Inc. GS were the biggest drags on the Dow Jones Industrial Average DJIA, even as both companies reported first-quarter profit that topped expectations. J&J’s stock fell $3.92, or 2.4%, as the drug maker recorded a large charge as it settled lawsuits stemming from its talc-containing powders. Goldman’s stock shed $6.37, or 1.9, after the banker and broker’s profit beat, but revenue fell short. The two stocks’ combined $10.
... Shares of Johnson & Johnson JNJ and Goldman Sachs Group Inc. GS were the biggest drags on the Dow Jones Industrial Average DJIA , even as both companies reported first-quarter profit that topped expectations. J&J’s stock fell $3.92, or 2.4%, as the drug maker recorded a large charge as it settled lawsuits stemming from its talc-containing powders. Goldman’s stock shed $6.37, or 1.9, after the banker and broker’s profit beat, but revenue fell short. The two stocks’ combined $10.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Stocks making the biggest moves premarket: Johnson & Johnson, Goldman Sachs, Sunrun and moreShares of Goldman Sachs shed nearly 4% after missing revenue estimates in its first-quarter earnings released before Tuesday's opening bell.
Read more »
JNJ Stock Price | Johnson & Johnson Stock - Investing.comGet today's JNJ stock price and latest Johnson & Johnson stock news as well as JNJ real-time stock quotes, technical analysis, full financials and more.
Read more »
Johnson & Johnson beats Q1 consensus estimates and raises guidanceJohnson & Johnson’s stock rose 1.4% in premarket trade Tuesday, after the consumer health and pharma company beat consensus estimates for its first quarter...
Read more »
Johnson & Johnson Posts Higher Quarterly Sales, Raises 2023 OutlookFirst-quarter earnings were wiped out by a $6.9 billion charge tied to litigation and other costs from its Covid-19 vaccine commitments.
Read more »
Johnson & Johnson beats on earnings and revenue, raises full-year guidanceEARNINGS: J&J reported adjusted earnings and revenue that topped Wall Street’s expectations, and lifted its full-year forecast. CFO Joseph Wolk joins us to discuss.
Read more »
Goldman Sachs Group stock loses ground as revenue falls shortGoldman Sachs Group Inc. stock is down 2.5% in premarket trades after its first-quarter revenue fell short of estimates, while its net income beat the Wall...
Read more »